161. Familial benign chronic pemphigus Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 6 / Drugs : 6 - (DrugBank : 3) / Drug target genes : 2 - Drug target pathways : 29
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Botulism toxin treatment
University Hospital, Toulouse
2015 Phase 1 NCT02782702 -
Celecoxib
Juntendo university gradurate school of medicine
2013 - JPRN-UMIN000010191 Japan
Doxycycline
Gangnam Severance Hospital
2020 - NCT05007223 Korea, Republic of
Guselkumab
Yale University
2025 Phase 2 NCT06651489 United States
LX3305 250 MG capsule
Dermecular Therapeutics, Inc.
2018 Phase 1;Phase 2 EUCTR2018-000373-80-FR France
Scenesse
ISTITUTI FISIOTERAPICI OSPITALIERI
2013 Phase 2 EUCTR2013-004562-33-IT Italy
University Hospital, Toulouse
2015 Phase 1 NCT02782702 -
Celecoxib
Juntendo university gradurate school of medicine
2013 - JPRN-UMIN000010191 Japan
Doxycycline
Gangnam Severance Hospital
2020 - NCT05007223 Korea, Republic of
Guselkumab
Yale University
2025 Phase 2 NCT06651489 United States
LX3305 250 MG capsule
Dermecular Therapeutics, Inc.
2018 Phase 1;Phase 2 EUCTR2018-000373-80-FR France
Scenesse
ISTITUTI FISIOTERAPICI OSPITALIERI
2013 Phase 2 EUCTR2013-004562-33-IT Italy